← All Mainz Biomed NV filings

Mainz Biomed NV 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

MYNZ
Mainz Biomed NV
10-Q: Quantum Cyber Pivots to AI/Quantum Drones, Divests Diagnostics
Quantum Cyber N.V. (formerly Mainz Biomed N.V.) reported substantial operating losses for Q2 2026, driven by significant R&D investments in its new AI and quantum drone technology focus, alongside the divestiture of its diagnostic testing business.